Site # 406 — Rochester, Minnesota

Site # 406 is a clinical research site located in Rochester, Minnesota, United States 55901.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site # 406 has participated in 1 clinical trials.

Therapeutic areas: Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma.

Sponsors: Pharmacyclics LLC..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Rochester

Browse all research sites in Minnesota · View every site in Rochester

• Rochester Methodist Hospital, Mayo Clinic
• University of Rochester Medical Center - Strong Memorial Hospital
• Mayo Clinic Hospital, Methodist Campus
• Mayo Clinic Rochester, Methodist Hospital Campus
• Mayo Clinic Hospital Rochester /ID# 269643
• Mayo/St. Mary's Hospital
• Mayo Clinic Foundation-Hospital
• Mayo Clinic Hospital Rochester /ID# 278995
• St. Marys Hospital/ MAYO Clinic
• Mayo Clinic Hospital
• Ohio State University Telemedicine
• Mayo Clinic Hospital - College of Medicine

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site # 406?

Site # 406 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site # 406 conducted?

Site # 406 has 1 clinical trials on record. Their work covers Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma.

Is Site # 406 accredited by Crixeo Clinical Trials?

Site # 406 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site # 406?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.